Skip to main content
Top
Published in: Cancer Cell International 1/2021

Open Access 01-12-2021 | osteosarcoma | Correction

Correction to: microRNA-338-3p inhibits proliferation, migration, invasion, and EMT in osteosarcoma cells by targeting activator of 90 kDa heat shock protein ATPase homolog 1

Authors: Riliang Cao, Jianli Shao, Yabin Hu, Liang Wang, Zhizhong Li, Guodong Sun, Xiaoliang Gao

Published in: Cancer Cell International | Issue 1/2021

Login to get access

Excerpt

Following the publication of the original article [1], we were notified that the representative images for migration of Saos2 cells in Fig. 5A had been misused. The statistics are not wrong and the mistake doesn't affect the conclusion of the paper. The correct Fig. 5 and caption are shown in this correction.
Metadata
Title
Correction to: microRNA-338-3p inhibits proliferation, migration, invasion, and EMT in osteosarcoma cells by targeting activator of 90 kDa heat shock protein ATPase homolog 1
Authors
Riliang Cao
Jianli Shao
Yabin Hu
Liang Wang
Zhizhong Li
Guodong Sun
Xiaoliang Gao
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2021
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-021-02283-2

Other articles of this Issue 1/2021

Cancer Cell International 1/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine